NRAS and neoplasm: The discrepancy in tumor location between BRAF- and NRAS-mutated melanomas can be attributed to the differing sensitivity of BRAF- and NRAS-mutant melanocytes to ultraviolet (UV) light-induced carcinogenesis, with BRAF-mutated melanocytes exhibiting greater sensitivity to UV-mediated damage [10].